The House Energy and Commerce Health Subcommittee today approved by voice vote the Synthetic Drug Control Act (H.R. 3537). The AHA-supported legislation would give the Drug Enforcement Administration authority to stop the distribution, sale and use of additional synthetic drugs by classifying them as Schedule I controlled substances. Since 2012, when 26 types of synthetic drugs were added to Schedule I, “many new synthetic substances have entered the market, leading to devastating health consequences and increased mortality, particularly among the nation’s youth,” AHA Executive Vice President Tom Nickels said in a letter of support for the bill.